LegoChem Biosciences, Inc.
25Patents
25Active
25Granted
52Portfolio score
Filing activity: Sep 22, 2009 → Nov 12, 2021 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9919057B2 | Compounds comprising self-immolative group | Chemistry; Metallurgy | 16 | Active |
| US10183997B2 | Compositions and methods related to anti-CD19 antibody drug conjugates | Emerging Cross-Sectional Technologies | 14 | Active |
| US9993568B2 | Compounds comprising self-immolative group | Chemistry; Metallurgy | 13 | Active |
| US10118965B2 | Compositions and methods related to anti-EGFR antibody drug conjugates | Human Necessities | 12 | Active |
| US9669107B2 | Antibody-active agent conjugates and methods of use | Chemistry; Metallurgy | 12 | Active |
| US10980890B2 | Compounds comprising self-immolative group | Chemistry; Metallurgy | 10 | Active |
| US10383949B2 | Compounds comprising self-immolative group | Chemistry; Metallurgy | 9 | Active |
| US11167040B2 | Conjugates comprising peptide groups and methods related thereto | Human Necessities | 8 | Active |
| US11173214B2 | Antibody-drug conjugates comprising branched linkers and methods related thereto | Human Necessities | 8 | Active |
| US11413353B2 | Conjugates comprising self-immolative groups and methods related thereto | Emerging Cross-Sectional Technologies | 6 | Active |
| US8329684B2 | Cephalosporin derivatives and pharmaceutical compositions thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US11654197B2 | Pyrrolobenzodiazepine dimer prodrug and ligand-linker conjugate compound of the same | Chemistry; Metallurgy | 2 | Active |
| US10961242B2 | Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same | Chemistry; Metallurgy | 2 | Active |
| US8242113B2 | Oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone pharmaceutical compositions thereof | Human Necessities | 2 | Active |
| US11707533B2 | Antibody-drug conjugate comprising antibody against human ROR1 and use for the same | Chemistry; Metallurgy | 2 | Active |
| US11548883B2 | Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same | Chemistry; Metallurgy | 1 | Active |
| US9630977B2 | Cephalosporin derivatives and pharmaceutical compositions thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11975076B2 | Antibody-drug conjugates comprising branched linkers and methods related thereto | Human Necessities | 1 | Active |
| US9951072B2 | Compositions and methods for inhibiting beta-lactamase | Chemistry; Metallurgy | 1 | Active |
| US11827703B2 | Compositions and methods related to anti-CD19 antibody drug conjugates | Chemistry; Metallurgy | 1 | Active |
| US8846669B2 | Oxazolidinone derivative and medical composition containing same | Human Necessities | 0 | Active |
| US8703939B2 | Method for preparing (R)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1H)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives | Chemistry; Metallurgy | 0 | Active |
| US10583197B2 | Antibody-active agent conjugates and methods of use | Chemistry; Metallurgy | 0 | Active |
| US9988372B2 | Crystalline form of 5-chloro-N-({(5S)-2-oxo-3-[4-(5,6-dihydro-4H-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide methanesulfonate and pharmaceutical composition comprising same | Chemistry; Metallurgy | 0 | Active |
| US10273235B2 | Compositions and methods for inhibiting β-lactamase | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.